Molecular convergence of luminal androgen receptor and molecular apocrine defines a distinct entity in ER-negative breast tumors
{{output}}
Background: Estrogen receptor-negative breast cancers are clinically heterogeneous. Two subtypes, Luminal Androgen Receptor and Molecular Apocrine Breast Cancers, are both defined by androgen signaling but identified through dist... ...
